Reck, M., Gale, D., Zhu, Z., Harpole, D. H., Taube, J. M., Mitsudomi, T., Luong, D. V., Hochmair, M., Lee, K., Horio, Y., Urban, L., Akamatsu, H., Biswas, B., Antonuzzo, L., Szalai, Z., Stewart, R., Lai, Z., Hodgson, D., Fouad, T. M., Heymach, J. (2025). Association of post-surgical MRD status with neoadjuvant ctDNA dynamics, genomic mutations, and clinical outcomes in patients with resectable NSCLC (R-NSCLC) from the phase 3 AEGEAN trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8009